1. HOME
2. Research Insight
3. mimedx (US) and Smith+Nephew (UK) are Leading Players in the Amniotic Products Market

The global Amniotic Products Market is projected to reach USD 1,289 million by 2028 from USD 900  million in 2023, at a CAGR of 7.4% during the forecast period. The growth of this market is due to the rising incidence of burn injuries and increasing number of traumatic wounds. However, High cost of amniotic membrane products may restrain the growth of this market.

The Amniotic Products Market is highly consolidated and is dominated by various players. mimedx (US), Smith+Nephew (UK), Organogenesis Inc. (US), Integra LifeSciences (US), Stryker (US), APPLIED BIOLOGICS. (US), Celularity Inc. (US), Corza Ophthalmology (US), Lucina BioSciences (US), and Next Biosciences. (South Africa).

To know about the assumptions considered for the study download the pdf brochure

mimedx (US)

mimedx is the leading player in the amniotic products market, with a market share of 30-33% in 2022. The company’s large share can be attributed to its broad range of amniotic-based products. The company has supplied more than 1.8 million placental tissue-based allografts for various applications in the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. The company has two distribution channels—direct to customers (healthcare professionals and/or facilities) and sales through distributors. The company also focuses on inorganic development which helps them expand the business in other regions, such as in 2021, the company secured regulatory approval for EPIFIX in Japan followed by reimbursement approval in 2022. They also announced distribution agreement with Gunze Medical Limited (“Gunze Medical”), a subsidiary of Gunze Limited, for sales of EPIFIX in the Japanese market, and expect to commence sales in the region in 2023.

Smith+Nephew (UK)

Ecolab Smith+Nephew held the second position in the amniotic products market, with a share of 19-22% in 2022. Smith+Nephew, the second-largest player in the advanced wound management market, has a robust portfolio and a strong geographic presence in key geographies. Over the years, the company has invested significant resources in broadening its product portfolio and enhancing its brand presence, which has made it a dominant player in the wound care market. It has also cultivated a wide and diverse network of suppliers. The company plans to launch Education Unlimited, a website platform for medical professionals to keep them updated with innovations taking place within the company. Likewise, to stay ahead in the market it focuses on technological advancements for instance, In Advanced Wound Management, company introduced the WOUND COMPASS Clinical Support App, which is a digital support tool for healthcare professionals that aids wound assessment and decision making to help reduce practice variation.

Organogenesis Inc. (US)

Organogenesis held the third position in the amniotic products market, with a share of 14-17% in 2022. Organogenesis is a prominent player in the amniotic products market owing to its strong brand recognition and comprehensive suite of amniotic products such as NuShield, and Affinity. The company has a robust brand presence, serving more than 4,000 healthcare facilities, including hospital systems, IDNs, and GPOs. The company has a robust pipeline of products with applications in advanced wound care and surgical & sports medicine market.

Integra LifeSciences (US)

Integra LifeSciences held the fourth position in the amniotic products market, with a share of 7-9% in 2022. The company’s leading position in this market can be attributed to its strong brand recognition and extensive product portfolio of amniotic products. In addition to new product development, the company is funding studies to gather clinical evidence to support launches, ensure market access and improve reimbursement for existing products. In addition to acquisitions and organic reinvestment, it continually looks to optimize portfolio towards higher growth and higher margin businesses. For instance, the company has made several acquisitions in the past few years to enhance its growth in the amniotic products market, such as the acquisitions of A Cell, Inc. in 2021 and with Innovation Associates, Inc. ("SIA") in 2022.

Related Reports:

Amniotic Products Market by Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospital & Ambulatory Surgical Centers) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]